慢性肾脏病患者限钠:自我管理支持的随机对照试验
在荷兰4家医院中,对中度肾功能下降的慢性肾脏病患者开展开放随机对照试验,比较常规照护与常规照护联合教育、动机性访谈、辅导及血压和钠自我监测的干预效果。干预3个月时干预组钠排泄率、日间动态舒张压、诊室舒张压、蛋白排泄改善且自我效能提高,6个月时钠排泄率和动态血压组间差异不显著,但诊室收缩压和舒张压、蛋白排泄及自我效能仍有差异。
要点
- 干预3个月时干预组钠排泄率较常规照护组降低30.3 mmol/24h(95%CI -54.7至-5.9)。
- 干预6个月时两组钠排泄率和动态血压差异不显著,但诊室收缩压和舒张压仍较低。
- 两组肾功能、降压药物和健康相关生活质量无差异。
核心结论
- 与仅常规照护相比,该自我管理干预适度改善了结局,但对钠排泄和动态血压的效果随时间减弱。
研究设计与样本
- 开放随机对照试验,纳入荷兰4家医院中度肾功能下降的慢性肾脏病患者,干预组67例、常规照护组71例。
主要发现
- 基线平均钠排泄率163.6±64.9 mmol/24h,平均估算肾小球滤过率49.7±25.6 mL/min/1.73m²,中位蛋白排泄率0.8(IQR 0.4-1.7)g/24h,平均24小时动态收缩压和舒张压分别为129±15和76±9 mmHg。
- 3个月时干预组较常规照护组钠排泄率平均变化-30.3(95%CI -54.7至-5.9)mmol/24h,日间动态舒张压平均变化-3.4(95%CI -6.3至-0.6)mmHg,诊室舒张压平均变化-5.2(95%CI -8.4至-2.1)mmHg,蛋白排泄平均变化-0.4(95%CI -0.7至-0.1)g/24h,自我效能平均变化0.5(95%CI 0.1至0.9)。
- 6个月时两组钠排泄率和动态血压差异不显著,但诊室收缩压和舒张压平均变化分别为-7.3(95%CI -12.7至-1.9)和-3.8(95%CI -6.9至-0.6)mmHg,蛋白排泄平均变化-0.3(95%CI -0.6至-0.1)g/24h,自我效能平均变化0.5(95%CI 0.0至0.9)。
- 两组肾功能、降压药物和健康相关生活质量无差异。
临床怎么用
- 原文未据此给出推荐。
局限性
- 非盲法。
- 应答率相对较低。
- 存在缺失数据。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: To evaluate the effectiveness and sustainability of self-managed sodium restriction in patients with chronic kidney disease. STUDY DESIGN: Open randomized controlled trial. SETTING & PARTICIPANTS: Patients with moderately decreased kidney function from 4 hospitals in the Netherlands. INTERVENTION: Regular care was compared with regular care plus an intervention comprising education, motivational interviewing, coaching, and self-monitoring of blood pressure (BP) and sodium. OUTCOMES: Primary outcomes were sodium excretion and BP after the 3-month intervention and at 6-month follow-up. Secondary outcomes were protein excretion, kidney function, antihypertensive medication, self-efficacy, and health-related quality of life (HRQoL). RESULTS: At baseline, mean sodium excretion rate was 163.6±64.9 (SD) mmol/24 h; mean estimated glomerular filtration rate was 49.7±25.6mL/min/1.73m2; median protein excretion rate was 0.8 (IQR, 0.4-1.7) g/24 h; and mean 24-hour ambulatory systolic and diastolic BPs were 129±15 and 76±9mmHg, respectively. Compared to regular care only (n=71), at 3 months, the intervention group (n=67) showed reduced sodium excretion rate (mean change, -30.3 [95% CI, -54.7 to -5.9] mmol/24 h), daytime ambulatory diastolic BP (mean change, -3.4 [95% CI, -6.3 to -0.6] mmHg), diastolic office BP (mean change, -5.2 [95% CI, -8.4 to -2.1] mmHg), protein excretion (mean change, -0.4 [95% CI, -0.7 to -0.1] g/24h), and improved self-efficacy (mean change, 0.5 [95% CI, 0.1 to 0.9]). At 6 months, differences in sodium excretion rates and ambulatory BPs between the groups were not significant, but differences were detected in systolic and diastolic office BPs (mean changes of -7.3 [95% CI, -12.7 to -1.9] and -3.8 [95% CI, -6.9 to -0.6] mmHg, respectively), protein excretion (mean changes, -0.3 [95% CI, -0.6 to -0.1] g/24h), and self-efficacy (mean change, 0.5 [95% CI, 0.0 to 0.9]). No differences in kidney function, medication, and HRQoL were observed. LIMITATIONS: Nonblinding, relatively low response rate, and missing data. CONCLUSIONS: Compared to regular care only, this self-management intervention modestly improved outcomes, although effects on sodium excretion and ambulatory BP diminish over time.
引用
- Meuleman Y, Hoekstra T, Dekker FW, et al. Sodium Restriction in Patients With CKD: A Randomized Controlled Trial of Self-management Support. Am J Kidney Dis. 2016. PMID: 27993433. doi:10.1053/j.ajkd.2016.08.042
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。